Assessing the Use of Mobile Technology in Adult Asthma Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

104 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-04-21

Study Completion Date

2018-08-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, remote observational study of adults with persistent asthma who are managed on inhaled corticosteroids.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Use of the Propeller Health Platform to Improve Inhaled Corticosteroid (ICS) Use Among Adults With Uncontrolled Persistent Asthma

NCT03860519

Asthma

COMPLETED NA

The Feasibility of Asthma Application of Mobile Phone and Mobile Spirometry for Home Monitor of Asthma Patients

NCT04808089

Asthma

UNKNOWN NA

Feasibility of a Smartphone Application for Asthma Self-management

NCT05572177

Asthma Chronic

RECRUITING NA

Automated Device for Asthma Monitoring

NCT01696357

Asthma

COMPLETED

Optimizing a Sensor-Enabled mHealth Intervention for Adolescents With Suboptimal Asthma Control

NCT07301060

Asthma (Diagnosis)

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study consists of one interventional group and all 104 subjects will be included in this group. All subjects will be provided with the HeroTracker package, which includes:

1. HeroTracker sensor that counts dosage and monitors real-time medication adherence
2. BreatheSmart mobile application that sends subjects real-time alerts and allows patients respond to questionnaires / surveys.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BreatheSmart

104 subjects will be provided with the BreatheSmart platform, which consists of:

1. HeroTracker sensor that monitors real-time asthma medication adherence
2. BreatheSmart mobile application that provides patients with real-time alerts, environmental information (weather, pollution, etc.), and the ability to complete questionnaires / surveys.

Group Type EXPERIMENTAL

BreatheSmart

Intervention Type DEVICE

BreatheSmart is a comprehensive asthma monitoring system that combines a medical device and mobile application that are designed for use with Apple and Android mobile devices. The medical device connects to the mobile application using Bluetooth to facilitate the collection of controlled medication adherence, rescue medication usage, and asthma control.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BreatheSmart

BreatheSmart is a comprehensive asthma monitoring system that combines a medical device and mobile application that are designed for use with Apple and Android mobile devices. The medical device connects to the mobile application using Bluetooth to facilitate the collection of controlled medication adherence, rescue medication usage, and asthma control.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ability to provide written informed consent
* Male and female adults (aged ≥ 18 years)
* Diagnosis of asthma for at least 6 months
* ICS (inhaled corticosteroid) use for at least 3 months
* Use of a pressurized metered dose inhaler (pMDI) compatible with the HeroTracker
* Possess a compatible smartphone (iOS 8.0 or higher and Android 4.3 or higher)

Exclusion Criteria

* Currently pregnant or planning to become pregnant during the study period
* Primary language other than English (BreatheSmart mobile app is currently available only in English)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No